ニュース

Fierce Pharma12 時間
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has ...
Fierce Pharma14 時間
Merck KGaA cites Trump tariffs, funding cuts as it scales back 2025 contracting forecast
As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...
Fierce Pharma13 時間
GSK sponsors Lifetime movie for meningitis B vaccine awareness, with help from 'Buffy' stars
A kidnapped child, a husband with a double life, a treacherous murder plot unraveled when the police arrive at the perfect ...
Fierce Pharma17 時間
Merck's Keytruda finds a path in ovarian cancer with phase 3 win in certain recurrent patients
Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. | ...
Fierce Pharma17 時間
Riding its Peloton buyout, Merck rolls to third FDA nod for potential blockbuster Welireg
Six years after Merck bought out Peloton Therapeutics, the New Jersey drugmaker is not remaining stationary with the crown ...
Fierce Pharma16 時間
Novartis, Sarepta tipped to drive genomic therapy sales toward $90B
GlobalData analysts have tipped the global market for genomic therapies to balloon to almost $90 billion by 2030, driven by ...
Fierce Pharma4 時間
Lilly's latest corporate campaign doubles as a recruitment drive
Eli Lilly has spent the last several years reintroducing itself to the public via a series of corporate campaigns. | Eli Lilly has spent the last several years reintroducing itself to the public via a ...